Record Series A for Italian Biotech Funds Autoimmune Therapy
Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for…
Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for…
People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their…
In Stockholm, Sweden, Sigrid Therapeutics is developing an ingestible silica powder that can treat type…
In a deal worth up to €67M, industry giant Nestlé Health Science will have the…
Will the daily routine of finger pricking to monitor blood glucose levels finally come to…
A genetic mutation common to Finnish populations has been found to protect against type 2…
Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin…
The first oral drug for type 2 diabetes belonging to the class of GLP-1 agonists,…
Six years ago, his three-year-old daughter was diagnosed with type 1 diabetes. This led Milos…
An immunotherapy designed by the Belgian biotech Imcyse to prevent type 1 diabetes has shown…
Diabetes has become an epidemic, sentencing over 422 million people worldwide to lifelong medication. Science…
A plant extract developed by the French biotech Valbiotis is the first food supplement to…